Your browser doesn't support javascript.
loading
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study.
Jones, Christopher M; O'Connor, Heather; O'Donovan, Maria; Hayward, Daniel; Blasko, Adrienn; Harman, Ruth; Malhotra, Shalini; Debiram-Beecham, Irene; Alias, Bincy; Bailey, Adam; Bateman, Andrew; Crosby, Tom D L; Falk, Stephen; Gollins, Simon; Hawkins, Maria A; Kadri, Sudarshan; Levy, Stephanie; Radhakrishna, Ganesh; Roy, Rajarshi; Sripadam, Raj; Fitzgerald, Rebecca C; Mukherjee, Somnath.
Afiliação
  • Jones CM; Department of Oncology, University of Cambridge, Cambridge, UK.
  • O'Connor H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • O'Donovan M; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Hayward D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Blasko A; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Harman R; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Malhotra S; Oncology Clinical Trials Office, University of Oxford, Oxford, UK.
  • Debiram-Beecham I; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Alias B; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Bailey A; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Bateman A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Crosby TDL; Southampton University Hospitals NHS Trust, Southampton, UK.
  • Falk S; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK.
  • Gollins S; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Hawkins MA; North Wales Cancer Treatment Centre, Glan Clwyd Hospital, Denbighshire, UK.
  • Kadri S; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Levy S; Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Radhakrishna G; Oncology Clinical Trials Office, University of Oxford, Oxford, UK.
  • Roy R; Department of Oncology, University of Oxford, Oxford, UK.
  • Sripadam R; Christie Hospital, The Christie Hospitals NHS Foundation Trust, Manchester, UK.
  • Fitzgerald RC; Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Hull, UK.
  • Mukherjee S; The Clatterbridge Cancer Centre, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
EClinicalMedicine ; 53: 101664, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36187722
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: EClinicalMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: EClinicalMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido